Insulin glargine /lixisenatide Fixed Ratio Combination

DRUG2 trials

Sponsors

Sanofi, Yanbing Li

Conditions

Type 2 DiabetesType 2 Diabetes Mellitus

Phase 2

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

CompletedNCT01476475

SanofiType 2 Diabetes Mellitus

Start: 2011-11-30End: 2012-12-31Updated: 2017-02-10

Phase 4

Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes

Not yet recruitingNCT07173712

Yanbing LiType 2 Diabetes

Start: 2026-03-15End: 2027-12-31Target: 324Updated: 2026-02-06